Novavax

IPO

Powering What's Possible

Public · Gaithersburg, United States · Founded 1987 · $2.0B raised

Employees
501–1000
Founded
1987
Business Model
B2B
Total Funding
$2.0B
Last Round
$330.0M Venture RoundFeb 2026
Rounds
5
Type
Public

About

Novavax is a global biotechnology company that discovers, develops, and commercializes vaccines for infectious diseases using its proprietary protein-based nanoparticle technology and Matrix-M adjuvant. Focused on maximizing R&D asset value through strategic partnerships, Novavax has developed vaccines targeting COVID-19, influenza, RSV, malaria, and other areas of unmet medical need. The company employs approximately 970 people and is headquartered in Gaithersburg, Maryland.

Summary

Novavax is a Healthcare company based in Gaithersburg, United States, founded in 1987. It has raised $2.0B in total across 5 rounds, most recently a $330.0M Venture Round round in Feb 2026. Investors include MidCap Financial, Operation Warp Speed (U.S. Government) and Coalition for Epidemic Preparedness Innovations (CEPI).

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundFeb 2026
$330.0M

Sign up to see all 5 rounds

Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Novavax on Indexed.vc
<a href="https://indexed.vc/companies/novavax"><img src="https://indexed.vc/api/badge/company/novavax" alt="Novavax on Indexed.vc" width="260" height="76" /></a>